Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment–naive patients significantly impact treatment outcomes

BB Simen, JF Simons, KH Hullsiek… - The Journal of …, 2009 - academic.oup.com
Abstract Background Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency
virus (HIV) variants may go undetected, yet be clinically important Objectives To compare …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

BB Simen, JF Simons, KH Hullsiek… - Journal of …, 2009 - augusta.elsevierpure.com
Background. Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency virus
(HIV) variants may go undetected, yet be clinically important. Objectives. To compare the …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.

BB Simen, JF Simons, KH Hullsiek, RM Novak… - 2009 - cabidigitallibrary.org
Abstract Background. Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency
virus (HIV) variants may go undetected, yet be clinically important. Objectives. To compare …

[PDF][PDF] Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

BB Simen, JF Simons, KH Hullsiek… - The Journal of …, 2009 - academia.edu
Background. Minor (ie, 20% prevalence) drug-resistant human immunodeficiency virus (HIV)
variants may go undetected, yet be clinically important. Objectives. To compare the …

[PDF][PDF] Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

BB Simen, JF Simons, KH Hullsiek… - The Journal of …, 2009 - scholar.archive.org
Background. Minor (ie, 20% prevalence) drug-resistant human immunodeficiency virus (HIV)
variants may go undetected, yet be clinically important. Objectives. To compare the …

[引用][C] Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes

BB SIMEN, J FREDRIK SIMONS… - The Journal of …, 2009 - pascal-francis.inist.fr
Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral
Treatment-Naive Patients Significantly Impact Treatment Outcomes CNRS Inist Pascal-Francis …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

BB Simen, JF Simons, KH Hullsiek, RM Novak… - 2009 - pubmed.ncbi.nlm.nih.gov
Background Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency virus
(HIV) variants may go undetected, yet be clinically important. Objectives To compare the …

[引用][C] Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

BB Simen, JF Simons, KH Hullsiek, RM Novak… - Journal of Infectious …, 2009 - cir.nii.ac.jp
Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral
Treatment–Naive Patients Significantly Impact Treatment Outcomes | CiNii Research CiNii 国立 …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.

BB Simen, JF Simons, KH Hullsiek… - The Journal of …, 2009 - europepmc.org
Background Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency virus
(HIV) variants may go undetected, yet be clinically important. Objectives To compare the …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

BB Simen, JF Simons, KH Hullsiek… - Journal of Infectious …, 2009 - experts.umn.edu
Background. Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency virus
(HIV) variants may go undetected, yet be clinically important. Objectives. To compare the …